These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9706492)

  • 1. Antagonistic effects of styrylpyrone derivative (SPD) on 7,12-dimethylbenzanthracene-induced rat mammary tumors.
    Hawariah A; Stanslas J
    In Vivo; 1998; 12(4):403-10. PubMed ID: 9706492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ; Yao ZX
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
    Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
    Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tamoxifen-dependent rat mammary tumors.
    Zimniski SJ; Warren RC
    Cancer Res; 1993 Jul; 53(13):2937-9. PubMed ID: 8319198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
    Gottardis MM; Jordan VC
    Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro response of human breast cancer cell lines to the growth-inhibitory effects of styrylpyrone derivative (SPD) and assessment of its antiestrogenicity.
    Hawariah A; Stanslas J
    Anticancer Res; 1998; 18(6A):4383-6. PubMed ID: 9891496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors.
    Matsumoto H; Koibuchi Y; Horiguchi J; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(1):145-51. PubMed ID: 11748473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
    Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring.
    Halakivi-Clarke L; Cho E; Onojafe I; Liao DJ; Clarke R
    Clin Cancer Res; 2000 Jan; 6(1):305-8. PubMed ID: 10656462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
    McDougal A; Wormke M; Calvin J; Safe S
    Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
    Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
    Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL; Mangel WF; Katzenellenbogen BS
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
    Fendl KC; Zimniski SJ
    Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
    Kosaka A; Yamashita A
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
    Ben-Hur H; Kossoy G; Zusman I
    Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
    Morimoto T; Yamamoto H; Komaki K; Konishi N; Tanaka T; Yamakawa T; Mori T; Sasa M; Monden Y
    Tokushima J Exp Med; 1990 Dec; 37(3-4):59-68. PubMed ID: 2128782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of tamoxifen in laboratory animals.
    Jordan VC; Allen KE; Dix CJ
    Cancer Treat Rep; 1980; 64(6-7):745-59. PubMed ID: 6775807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.